Industry & Business

€5 Billion Investment in Irish BioPharma Sector

 Breaking News
  • Technology Plays a Leading Role For Irish Business Leaders Business leaders across Ireland are firm believers in the power of technology and the important role it plays, not only in supporting their own business needs, but in overcoming the wider socioeconomic issues they face. According to research – Technology in a Transforming Ireland – of Irish business leaders commissioned by Fujitsu, nearly 6-in-10 (59 percent) say [...]...
  • Only 11% of Irish Businesses Using Renewable Energy Irish businesses have yet to make the switch to renewable energy but are looking for cleaner energy alternatives, according to new research from Calor Gas. Just 11% of Irish businesses report that they are using renewable energy. Of the businesses not using renewable energy, 85% are open to switching to a renewable alternative. The figures were [...]...
  • Research Reveals SMEs Lose €2.2 Billion a Year in Productivity Due to Administration Sage, a market leader in cloud accounting software, has revealed that Irish SMEs lose up to €2.2 billion annually in productivity due to burdensome administrative tasks. The report, ‘Sweating the Small Stuff: the impact of the bureaucracy burden’, undertaken by Plum Consulting, shows businesses in Ireland spend an average of 70 working-days per year navigating the [...]...
  • European Commission Takes Action For a More Competitive and Innovative Financial Market The European Commission has unveiled an Action Plan on how to harness the opportunities presented by technology-enabled innovation in financial services (FinTech). Europe should become a global hub for FinTech, with EU businesses and investors able to make most of the advantages offered by the Single Market in this fast-moving sector. As a first major deliverable, [...]...
  • 40% Think Irish Government Not Doing Enough to Protect Ireland From Impact of Brexit Brexit is coming closer and still a lot of questions remain unanswered. People are insecure not only about their own future but also the economic future of Ireland. iReach Insights conducted a nationally representative survey and 1,000 adults were asked about their opinion about the Brexit, it’s potential impact and what Irish people would do, [...]...

€5 Billion Investment in Irish BioPharma Sector

€5 Billion Investment in Irish BioPharma Sector
February 03
12:18 2017

Capital investment projects valued at €5 billion have been recently completed or are currently in progress across the Irish biopharma industry, according to Matt Moran, Director of BioPharmachem Ireland, the Ibec association representing the biopharma, pharma and chemical sectors in Ireland. BioPharaChem Ireland’s primary aim is to ensure that Ireland remains a recognised global centre of excellence for innovation and development in pharmaceutical, biopharmaceutical and chemical supply.

“There has been a significant uplift in investment in Ireland,” Moran said. “It is looking positive at the moment for the country.” Generating over €60 billion worth of exports (about half of total country exports), the sector is a major contributor to the Irish economy.

“We are very much in expansionary mode,” Moran added.

However, to maintain this momentum, the Irish biopharma sector faces a number of key challenges, which were outlined by Moran in a keynote presentation at the recent National Manufacturing & Supply Chain Conference & Exhibition held at the Citywest Hotel, Dublin.

 He identified a number of key challenges facing the Irish biopharma sector if it is to maintain its current competitive advantages and continue in its role as a global centre of manufacturing, supply and development for the entire pharma sector – from small through medium to large molecule.

Ireland needs to ensure that it continues to create a competitive environment to promote growth, innovation and operational excellence. While it has a competitive rate of corporation tax, Ireland’s personal tax regime may prove problematic in attracting and retaining talented people within Irish industry. While Ireland’s talent pool remains a key global competitive advantage, it is essential to continue to ensure that highly trained people are available for the biopharma industry. Similarly, it is crucial that Ireland’s reputation as a global hub for innovation and manufacturing excellence is maintained.

Another key advantage enjoyed by the biopharma sector is the productive collaboration between industry, academia and government agencies. Over half of the Irish biopharma workforce has third level education. It is vital that this academic collaboration continues to consolidate Ireland’s position as a knowledge-based economy and as a primary location for R&D.

Continuity of investment in education is critical to ensuring that the necessary skills remain available to the industry. BioPharmachem Ireland advocates an increase in spending on science, technology and innovation to 2.5% of GDP by 2020.

“Ireland is recognised as a leading global location with regard to compliance with statutory and quality regulations,” Moran noted, indicating that this gives Irish companies a key competitive advantage over industries in other regions around the world. “The biopharma sector is very important for the country and it has the potential to grow further. It is important that we are not complacent. Our infrastructure needs to be state-of-the-art. Taxation, especially personal taxation, needs to be looked at.”

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4